Maharashtra allows use of homeopathy, ayurveda medicines to prevent Covid

On Wednesday, the Ayush Ministry had announced it is going to begin a clinical trial to measure Arsenic Album 30’s efficacy against Covid-19 in six cities of India. The Central Council for Research in Homeopathy (CCRH) has obtained clearance to start a trial in Delhi, Mumbai, Kolkata, Surat, Hyderabad and Machilipatnam. “The CCRH expects this to generate evidence to support homoeopathic intervention as mass prophylaxis against Covid-19,” the ministry said.

Till now, there is no evidence to suggest Arsenicum Album 30 prevents Covid-19 infection. The medicine is generally used for respiratory problems. Several homeopathic experts have expressed worry over unscientific use of the medicine against Covid-19.

In Mumbai, the medicine was first distributed in May among the high-risk population in containment zones of two wards. Its distribution had begun across all 24 wards after the state allowed its use on June 8.

“We have issued notified all stakeholders. We are giving this medicine to high-risk populations across the city now ,” said Suresh Kakani, Additional Municipal Commissioner.

On June 8, the task force appointed by Maharashtra government had submitted its report listing Unani, Ayurvedic and homeopathic medicines as prophylactic or immunity boosters. It had recommended taking Arsenicum Album 30 for three days and to repeat the dose after a month if the Covid-19 pandemic continued in local vicinity .

The state notification has recommended several Ayurvedic medicines – herbal medicine Sanshamani Vati 500 mg for 15 days, Ayush 64 tablet for 15 days and Agastya Haritaki for 15 days. Sanshamani Vati is used to treat fever, Ayush 64 is an anti-malarial tablet, while Agastya Haritaki is used for respiratory problems.

ASHA worker Netradeepa Patil, based in Kolhapur, said they have been instructed to prepare a list of all people aged above 55 years in rural areas. “We have to administer them Arsenicum Album 30 for three days and repeat the dose if needed. Several people who are less than 55 years have also demanded that they be allowed to take this medicine,” Patil added.